POWERUP ACQUISITION CORP.

Company

Aspire Biopharma Holdings, Inc.

Filed

March 7, 2022

Accession Number

0000902664-22-002051

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →